Funded Tech Companies
Mabylon AG
Mabylon AG is a biopharmaceutical growth company, based in Schlieren. Venture capital investment was provided by private investors.
Company Overview
Company Name
Mabylon AG
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
Wagistrasse 14
Schlieren, 8952
Switzerland
Schlieren, 8952
Switzerland
Phone
Website
Email Address
Company Background Information
Overview
Mabylon AG is a Swiss biotechnology company leveraging its technology platform and unique know-how to discover and engineer novel antibody therapeutics in allergy, inflammation and neurology. The firm's strength stems from extensive and successful experiences in both the pharmaceutical and biotech industries. Mabylon's drug discovery goal is to rapidly create high-quality antibody libraries against validated targets from which the best functional, therapeutically relevant products are selected. To this aim, Mabylon has access to diverse sources of immune repertoires, focusing on patients with relevant conditions.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
8/12/2025
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Alcide Barberis
Company Investors
Browse more funded tech companies:
MabVax Therapeutics | Mac & Mia
Share this article
About Our Venture Capital Database
Our data comes from VentureDeal.com, a leading supplier of venture capital funding data.
Additional Resources for Entrepreneurs